NECTAR LIFESCIENCES
|
The Current P/E Ratio of NECTAR LIFESCIENCES is 13.76.
| Share Price | ₹10.2 | Nov 02,2026 |
| Market Cap | ₹197.6 Cr | |
| Earnings-TTM | ₹14.4 Cr | TTM-Consolidated Results |
| Price/Earnings | 13.76x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of NECTAR LIFESCIENCES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹197.6 Cr] as on Nov 02,2026
(/) Earnings [ ₹14.4 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 13.76x ]
Thus, for NECTAR LIFESCIENCES , the investors are currently willing to pay 13.76 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of NECTAR LIFESCIENCES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of NECTAR LIFESCIENCES over the last five years.
Historical PE (Price/Earnings) ratio chart of NECTAR LIFESCIENCES
PE Ratio Performance Analysis for NECTAR LIFESCIENCES
- NECTAR LIFESCIENCES 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 31.34x.
- NECTAR LIFESCIENCES 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, NECTAR LIFESCIENCES 's p/e ratio peaked in Mar2024 at 135.18x.
- NECTAR LIFESCIENCES 's p/e ratio hit its five-year low in Mar2026 of 0x.
How does NECTAR LIFESCIENCES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| NECTAR LIFESCIENCES | 14.36 | 13.76 | 197.6 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11,037.20 | 38.43 | 424,202.0 |
| DIVIS LABORATORIES LTD | 2,925.00 | 90.30 | 264,141.0 |
| TORRENT PHARMACEUTICALS LTD | 2,099.00 | 83.09 | 174,402.0 |
| CIPLA LTD | 2,868.29 | 38.93 | 111,650.0 |
| DR REDDYS LABORATORIES LTD | 2,759.70 | 40.54 | 111,868.0 |
| MANKIND PHARMA LTD | 2,249.69 | 45.43 | 102,196.0 |
| LUPIN LTD | 5,551.01 | 16.45 | 91,300.8 |
| ZYDUS LIFESCIENCES LTD | 4,492.20 | 27.53 | 123,685.0 |
| AUROBINDO PHARMA LTD | 3,712.74 | 26.11 | 96,951.2 |
| LAURUS LABS LTD | 1,333.75 | 95.08 | 126,811.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs NECTAR LIFESCIENCES 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 13.76x |
| Max industry PE | 95.08x |
| Median industry PE | 38.93x |
| Average industry PE | 46.88x |
You may also like the below Video Courses